CURALEAF U.K. LIMITED

11538075
Active London

Other research and experimental development on natural sciences and engineering

2 employees website.com
Healthcare and wellbeing Other research and experimental development on natural sciences and engineering
C

CURALEAF U.K. LIMITED

11538075

Other research and experimental development on natural sciences and engineering

Founded 25 Aug 2018 Active London, United Kingdom 2 employees website.com
Healthcare and wellbeing Other research and experimental development on natural sciences and engineering

Previous Company Names

EMMAC U.K. LIMITED 25 Aug 2018 — 22 Oct 2021
Accounts Submitted 6 Oct 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 11 Sept 2025 Next due 7 Sept 2026 2 months remaining
Net assets £3M
Total assets £6M £0 2024 year on year
Total Liabilities £3M £3M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Hill Dickinson Llp, The Broadgate Tower 20 Primrose Street London EC2A 2EW United Kingdom

Website

www.example.com

Full company profile for CURALEAF U.K. LIMITED (11538075), an active healthcare and wellbeing company based in London, United Kingdom. Incorporated 25 Aug 2018. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

N/A

Net Assets

£2.50M

Total Liabilities

£3.21M

Decreased by £2.50M (-44%)

Turnover

N/A

Employees

2

Debt Ratio

56%

Decreased by 44 (-44%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Curaleaf International Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 25 Aug 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

CURALEAF U.K. LIMITED Current Company
CURALEAF PHARMACY LTD united kingdom
ROKSHAW LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Dec 2025OfficersAppointment of Mr Ilia Gruzdev as director on 28 Nov 2025
2 Dec 2025OfficersTermination of Peter Charles Michael Doona as director on 28 Nov 2025
6 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
11 Sept 2025Confirmation StatementConfirmation statement made on 24 Aug 2025 with no updates
12 Oct 2024AccountsAnnual accounts made up to 31 Dec 2023
2 Dec 2025 Officers

Appointment of Mr Ilia Gruzdev as director on 28 Nov 2025

2 Dec 2025 Officers

Termination of Peter Charles Michael Doona as director on 28 Nov 2025

6 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

11 Sept 2025 Confirmation Statement

Confirmation statement made on 24 Aug 2025 with no updates

12 Oct 2024 Accounts

Annual accounts made up to 31 Dec 2023

Recent Activity

Latest Activity

Appointment of Mr Ilia Gruzdev as director on 28 Nov 2025

6 months ago on 2 Dec 2025

Termination of Peter Charles Michael Doona as director on 28 Nov 2025

6 months ago on 2 Dec 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 6 Oct 2025

Confirmation statement made on 24 Aug 2025 with no updates

9 months ago on 11 Sept 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 12 Oct 2024